tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TPST Stock Latest News

Tempest Therapeutics Reports Q3 2025 Financial Results
Company AnnouncementsTempest Therapeutics Reports Q3 2025 Financial Results
6d ago
TPST
Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year
PremiumThe Fly
Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year
7d ago
TPST
TPST Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TPST Earnings this Week: How Will it Perform?
9d ago
TPST
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
PremiumCompany Announcements
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
15d ago
ADAG
TPST
Tempest Therapeutics’ Promising Phase 3 Trial for Liver Cancer Treatment
PremiumCompany Announcements
Tempest Therapeutics’ Promising Phase 3 Trial for Liver Cancer Treatment
15d ago
TPST
Six new option listings and option delistings on October 20th
PremiumThe FlySix new option listings and option delistings on October 20th
23d ago
CLPS
FLOT
Tempest Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Tempest Therapeutics Reports Q2 2025 Financial Results
3M ago
TPST
Tempest Therapeutics reports Q2 EPS ($2.07), consensus ($2.65)
Premium
The Fly
Tempest Therapeutics reports Q2 EPS ($2.07), consensus ($2.65)
3M ago
TPST
Tempest Therapeutics, Inc. (TPST) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Tempest Therapeutics, Inc. (TPST) Q2 Earnings Cheat Sheet
3M ago
TPST
Morpheus-Liver Study: A New Horizon in Advanced Liver Cancer Treatment
PremiumCompany Announcements
Morpheus-Liver Study: A New Horizon in Advanced Liver Cancer Treatment
3M ago
TPST
Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment
PremiumCompany Announcements
Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment
4M ago
TPST
Tempest Therapeutics receives NMPA clearance to proceed with amezalpat trial
PremiumThe Fly
Tempest Therapeutics receives NMPA clearance to proceed with amezalpat trial
4M ago
TPST
Tempest Therapeutics Secures $4.1M in Direct Offering
PremiumCompany AnnouncementsTempest Therapeutics Secures $4.1M in Direct Offering
5M ago
8K
TPST
Tempest prices 739,000 shares at $6.25 in registered direct offering
Premium
The Fly
Tempest prices 739,000 shares at $6.25 in registered direct offering
5M ago
TPST
Tempest Therapeutics Shifts Executives to Consulting Roles
Premium
Company Announcements
Tempest Therapeutics Shifts Executives to Consulting Roles
5M ago
8K
TPST
Tempest Therapeutics receives ODD from EMA for amezalpat
PremiumThe Fly
Tempest Therapeutics receives ODD from EMA for amezalpat
5M ago
TPST
Tempest Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Tempest Therapeutics Reports Q1 2025 Financial Results
6M ago
TPST
Tempest Therapeutics: Navigating Financial Challenges with Promising Clinical Data and Strategic Partnerships
PremiumRatings
Tempest Therapeutics: Navigating Financial Challenges with Promising Clinical Data and Strategic Partnerships
6M ago
TPST
Tempest Therapeutics reports Q1 EPS ($3.16), consensus ($3.29)
PremiumThe Fly
Tempest Therapeutics reports Q1 EPS ($3.16), consensus ($3.29)
6M ago
TPST
Cautious Optimism for Tempest Therapeutics Amid Strategic Reorganization and Promising Amezalpat Data
PremiumRatingsCautious Optimism for Tempest Therapeutics Amid Strategic Reorganization and Promising Amezalpat Data
7M ago
TPST
Tempest Therapeutics announces FDA granted ODD to TPST-1495
Premium
The Fly
Tempest Therapeutics announces FDA granted ODD to TPST-1495
7M ago
TPST
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
ADTX
CRMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >